MedPath

C-M COMPOSITUM - LIQ

C-M COMPOSITUM - LIQ

Discontinued
DIN Number

02121239

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

weleda ag heilmittelbetriebe

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02121239
AIG Number0426593001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (4)

CHAMOMILEActive
Strength: 3 D / ML
Monograph: CHAMOMILE
CUPRIC CARBONATE BASICActive
Strength: 6 D / ML
Monograph: CUPRIC CARBONATE BASIC
POTASSIUM ACETATEActive
Strength: 6 D / ML
Monograph: POTASSIUM ACETATE
TOBACCOActive
Strength: 10 D / ML
Monograph: TOBACCO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.